Rxo (RXO) Leases (2021 - 2026)

Rxo (RXO) has 6 years of Leases data on file, last reported at $222.0 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 13.28% year-over-year to $222.0 million; the trailing twelve-month figure through Mar 2026 stood at $222.0 million (down 13.28% YoY), and the FY2025 full-year result was $238.0 million, down 13.77% from the prior year.
• Leases for Q1 2026 stood at $222.0 million, down from $238.0 million in the prior quarter.
• Across five years, Leases topped out at $333.0 million in Q3 2024 and bottomed at $7.0 million in Q4 2022.
• The 5-year median for Leases is $210.0 million (2024), against an average of $193.7 million.
• The widest annual swing landed in 2022, when Leases sank 94.53%; it then soared 2966.67% in 2024.
• A 5-year view of Leases shows it stood at $7.0 million in 2022, then advanced by 28.57% to $9.0 million in 2023, then jumped by 2966.67% to $276.0 million in 2024, then decreased by 13.77% to $238.0 million in 2025, then dropped by 6.72% to $222.0 million in 2026.
• The last three Leases figures came in at $222.0 million (Q1 2026), $238.0 million (Q4 2025), and $254.0 million (Q3 2025), per Business Quant data.

Peer Comparison